Business
DKSH expands into Middle East with $390 million healthcare acquisition
Swiss trading group DKSH is buying Dubai-based Newbridge Pharmaceuticals for $390 million, expanding its healthcare business into the Middle East and North Africa. Newbridge distributes specialist medicines in 14 markets, including Saudi Arabia and the United Arab Emirates.
4 days ago · 1 source



















